If you want to test the waters, reduce to the lowest effective maintenance dose rather than stopping entirely
In March 2026, the FDA sent warning letters to 30 telehealth companies for illegally marketing compounded GLP-1 drugs
Beyond quantitative preservation, maintaining skeletal muscle function, including strength and metabolic capacity, remains a critical therapeutic goal in ensuring long-term health outcomes
it's a nationwide regulation
Deleting -adrenergic receptors abrogates hepatic CAR activity in mice,46 and a pilot study has suggested that losartan, an adrenergic antagonist, mitigates nonalcoholic steatohepatitis and fibrosis in humans.49 Diagnostic and Therapeutic Implications Nonalcoholic steatohepatitis and its deadly sequelae, cirrhosis and liver cancer, are much less prevalent than isolated hepatic steatosis in the general population